The human cytochrome P450 (CYP) 3A gene subfamily members, which are the major hepatic and intestinal CYPs, are known to biotransform a wide variety of therapeutic drugs. 1, 2) In the known functional members which include CYP3A4, CYP3A5 and CYP3A7, 3) CYP3A4 expression is consistently observed in the adult liver, and the alteration of its encoded amino acids due to genetic polymorphisms has been reported. 4) On the other hand, CYP3A5 exhibits polymorphic expression in the human liver; namely, its mRNA and protein are detected in 10 to 30% of human adults. [5] [6] [7] [8] Additionally, CYP3A7, a major human fetal liver form, 9,10) is not expressed in the adult liver. Because of the great personto-person variability in CYP3A expression, care must be exercised when administering therapeutic drugs that are CYP3A substrates.
CYP3A5-like sequences including CYP3AP1 as reported by Finta and Zaphiropoulos. 16) This observed sequence similarity made it extremely difficult to analyze the CYP3A5 promoter.
In this paper, we constructed a series of primers that were able to distinguish between the CYP3A5 and the CYP3AP1. Furthermore, we sequenced the proximal promoter region of the CYP3A5 gene from 86 established cell lines derived from Japanese individuals as substitute for human samples in order to reveal putative SNPs affecting promoter activity.
MATERIALS AND METHODS

DNA Preparation
Established cell lines derived from 86 different Japanese individuals were obtained from either the Health Science Research Resources Bank (Osaka, Japan) or the Japanese Collection of Research Bioresources, National Institute of Health Sciences (Tokyo, Japan). These included 82 tumor cell lines (10 leukemias , 8 lymphomas, 18 lung tumors, 6 brain tumors, 2 hepatomas, 14 gastro-intestinal tumors, 3 thyroid carcinomas, 5 reproductive organ tumors, 2 mammary carcinomas, 4 oral tumors, 4 skin tumors, 3 osteosarcomas, and 3 embryonic tumors) and 4 normal cell lines (2 skin fibroblast and 2 embryonic fibroblast). The cells were cultured in RPMI1640 medium supplemented with 5-10% fetal calf serum at 37°C in a humidified atmosphere of 5% CO 2 and 95% air, according to the instructions of the bank. DNA extraction was carried out with approximately 5ϫ10 7 cells using the Blood and Cell Culture DNA Kit (Qiagen, Hilden, Germany). The concentrations of the obtained DNA solutions were determined by UV absorbance, and the DNA solutions were stored at 4°C until sequence analysis.
Sequencing of the CYP3A5 Promoter Primer design for the polymerase chain reaction (PCR) was based on the report of Paulussen et al. 15) and a draft sequence from the The members of the cytochrome P450 (CYP) 3A subfamily play an important role in the metabolism of more than 50% of the drugs metabolized by CYPs. Among the CYP3A members, CYP3A5 is known to exhibit polymorphic expression within the human liver. We hypothesized that a single nucleotide polymorphism (SNP) in the 5-regulatory region of the CYP3A5 gene might be the cause of CYP3A5 polymorphic expression. Due to the existence of "CYP3AP1," a highly homologous sequence to the CYP3A5 gene, it was necessary to make specific primers to the CYP3A5 gene. In the present study, we designed a series of oligonucleotide primers for sequencing the proximal promoter region of the CYP3A5 gene in order to search for the putative regulatory single nucleotide polymorphism. We examined 86 established cell lines derived from Japanese individuals as a representation of the Japanese population. However, no SNP was detected in the promoter region of the CYP3A5 gene isolated from the cell lines used, suggesting other causal factors for the observed polymorphism of CYP3A5-dependent drug metabolism.
Key words CYP3A5 gene; promoter sequence; cultured cell line; Japanese individual; genetic polymorphism; cytochrome P450 NCBI database (AC005020). All the primers used in this study are listed in Table 1 . DNA fragments of the CYP3A5 promoter from approximately 800 bp upstream to about 150 bp downstream of the translation initiation codon were amplified from genomic DNA, with the appropriate primers and Ex-Taq DNA polymerase (TaKaRa Co., Kyoto, Japan) using the GeneAmp PCR system 9700 (Perkin-Elmer Co., CA, U.S.A.). PCR conditions were: heat denaturation at 95°C for 5 min, followed by 30 cycles of 95°C for 30 s, 55°C for 1 min, 72°C for 2 min, and one final cycle of 72°C for 7 min. The PCR products were purified by a PCR product purification kit (USB Co., Ohio, U.S.A.). Subsequently, the purified DNAs were directly sequenced using one of the primers, which was applied in their amplification, on both strands by cycle sequencing using the ABI BigDye Terminator cycle sequencing kit (Perkin-Elmer Co., CA, U.S.A.). The excess dye was removed by using a Dye-Ex96 plate (Qiagen, Hilden, Germany). The eluants were analyzed on an ABI Prism 3700 DNA Analyzer (Perkin-Elmer Co., CA, U.S.A.). Using this method, a much smaller amount of cellular DNA was needed for sequencing than when genomic DNA was subjected to the sequencing reaction. Contiguous sequences were aligned and compared using GENETYX-WIN software (Software Development Co., Ltd., Tokyo).
RESULTS AND DISCUSSION
Individual differences in CYP3A5 expression have been reported for Caucasians by several laboratories. 7) Within the Japanese population, polymorphic expression has also been reported by Tateishi et al. 8) It is our hypothesis that genetic polymorphisms within the promoter region may be a cause for the polymorphic appearance of CYP3A5 expression. To understand CYP3A5 gene regulation, precise sequence information for the CYP3A5 promoter is indispensable. Recently, draft sequences of whole human genome have become available. We obtained draft sequences, including the CYP3A5 gene and neighboring sequences belonging to the CYP3A subfamily, from the NCBI database (AF280107 and AC005020). In addition, the genomic structure of the CYP3A subfamily was reported by Finta and Zaphiropoulos. 16 ) These data indicated that there was a sequence named "CYP3AP1", which was highly homologous but not identical to a CYP3A5 Fig. 1 . Electropherogram of the CYP3A5 Promoter Region Sequence Using Various Primer Sets DNA obtained from the JCRB0095 cell line was subjected to PCR and sequencing using various primer sets. Green, blue, black, and red represent adenine, cytosine, guanine, and thymine, respectively. A) The primers 3A5F(Ϫ90) and 3A5R(ϩ230) were used as forward and reverse primers, respectively. Arrows indicate sites where two different bases were observed. B) CYP3A5 sequence was determined by using 3A5F(Ϫ90) as a forward primer and 3A5R(ϩ255)A as a reverse primer. 3A5R(ϩ255)A specifically recognized the CYP3A5. C) CYP3AP1 was determined by using 3A5F(Ϫ364)B as a forward primer and 3A5R(ϩ105)B as a reverse primer. Both primers are specific for the CYP3AP1. The same results were obtained for the other cell lines. 
a) Primer locations are based on CYP3A5 sequence data of Jounaidi et al. 19) promoter region sequence. The 5Ј-upstream sequence reported by Paulussen et al. 15) that had been regarded as a CYP3A5 promoter sequence, was identical to that of CYP3AP1 and was different from the CYP3A5 promoter sequence.
In the direct sequencing, difficulty arose with primers that recognized multiply related or highly homologous genes. In the analysis of the CYP3A5 gene, these homologous sequences including CYP3AP1 made it difficult to read the CYP3A5 promoter sequences. Figure 1 shows the electropherogram obtained from the sequence profiles surrounding the transcription initiation site of CYP3A5 when DNA from the JCRB0095 cell line was subjected to PCR and sequencing using the various primer sets as indicated. The electropherogram in Fig. 1A included seven positions (indicated by arrows) where two different bases were recognized simultaneously. These were clearly distinguished as the two sequences shown in Figs. 1B and C by using specific primers. The two primers, called "3A5F(Ϫ90)" and "3A5R (ϩ255)A", revealed a portion of CYP3A5 (Fig. 1B) , while the other primers called "3A5F(Ϫ364)B" and "3A5R (ϩ105)B" revealed a portion of CYP3AP1 (Fig. 1C) . The same results were obtained for all other cell lines used in the present study. Thus we had primers that enabled us to distinguish the two related sequences of the CYP3A5 gene promoter and CYP3AP1. The primers labeled A and B (Table 1) are specific for CYP3A5 and CYP3AP1, respectively, and thus their specificities are indicated by the last letter of each primer name. Non-labeled primers amplified both sequences.
Within the CYP3A5 and CYP3AP1 sequences shown in Fig. 2 , there were more than 80 mismatched nucleotides between the two sequences for the region that included 670 bp upstream (based on sequence A) from the transcription start site and 100 bp of the 5Ј-untranslated region (UTR). The homology of these sequences was 89.6%. We then sequenced this region in 86 individual Japanese cell lines to search for putative regulatory SNPs. If polymorphic expression of CYP3A5 is caused by sequence differences within this region, regulatory SNPs should be observed more frequently. However, we were unable to find any SNP in this region. Instead, we suggest that, at least for the Japanese population, CYP3A5 polymorphism may be caused by (1) a more upstream region sequence, (2) a regulatory intron sequence, (3) mutation of transcriptional factor(s), or (4) differences in the expressed level of transcription factor(s). Further studies are needed to answer this question.
In this study, we used genomic DNA extracted from 86 different cultured cell lines as our DNA source. Using cell 956 Vol. 24, No. 8
Fig. 2. Nucleotide Sequences of the 5Ј-Flanking Region of the CYP3A5
Sequences derived from the CYP3A5 (upper) and the CYP3AP1 (lower) have been aligned as shown. The putative transcription initiation site (ϩ1) was assumed to be identical to the CYP3A4. 14) Identical nucleotides between the two sequences are shown by asterisks; deleted nucleotides are indicated by hyphens. The translation initiation codon, ATG, is doubly underlined. Putative regulatory elements previously identified for the CYP3A4 18) are indicated by dotted upper lines.
line DNA may have presented an increased risk of gene mutation(s), or chromosomal translocation(s), but our present analyses of all the cell lines used resulted in a sequence identical to the promoter region reference sequence (AC005020). Therefore, established cell lines may well be useful as genomic DNA sources for new SNP discoveries. Recently, Kuehl et al. reported that polymorphic CYP3A5 expression was caused by SNPs, which led to alternative splicing and thus resulted in an absence of CYP3A5 expression.
17) It might be of interest to compare frequencies of the alleles which include alternative splicing between Japanese and Caucasians.
In summary, we found no SNPs in the proximal promoter region of the CYP3A5, beginning 670 bp upstream from the transcription start site and ending 100 bp into the 5Ј-untranslated region (UTR), after examining 86 cell lines derived from Japanese individuals. We conclude that the sequence within this region is not likely to be the cause of the polymorphism of CYP3A5 expression.
